Use of Probiotics in the Treatment of Inflammatory Bowel Disease
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The gut flora plays a fundamental role in maintaining normal intestinal function. A disturbance of this flora, or the host response to this flora, has been clearly demonstrated to play a role in the pathogenesis of inflammatory bowel disease (IBD). This has led to attempts to modify the bacterial flora with "live non-pathogenic organisms that confer health benefits by improving the microbial balance," otherwise known as probiotics. Recent attention has focused on this potential strategy to treat or prevent IBD. The potential therapeutic benefit is enhanced by the natural and apparently safe approach that probiotics offer. Animal models of colitis have provided the proof of principle that probiotics can prevent and treat established intestinal inflammation. Controlled clinical studies have demonstrated the efficacy of probiotics in the maintenance of remission of pouchitis, prophylaxis of pouchitis after the formation of an ileoanal reservoir, maintenance of remission of ulcerative colitis, and treatment of Crohn's disease. However, large controlled trials are needed to definitively establish the place for probiotics in the treatment of IBD and resolve issues such as the dose, duration, frequency of treatment, and use of single or multiple strains. Research is focusing on establishing the mechanism of action, so that treatments with individually tailored properties are developed and innovative approaches are explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
Intestinal permeability and the prediction of relapse in Crohn's disease
Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90882-h · Cited by 626
Haller, D., Bode, C., Hammes, W. P., Pfeifer, A. M. A., Schiffrin, E. J., & Blum, S. (2000) · Gut · doi:10.1136/gut.47.1.79 · Cited by 466
Gupta, P., Andrew, H., Kirschner, B. S., & Guandalini, S. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200010000-00024 · Cited by 429
Salminen, S., Isolauri, E., & Salminen, E. (1996) · Antonie van Leeuwenhoek · doi:10.1007/bf00395941 · Cited by 406 · cited 1×
“They must be safe for human use, have clinically validated health effects, and be suitable for commercial production.(4) There are many probiotic strains currently available in over-the-counter preparations.”
BackgroundLactobacilli and Bacteremia in Southern Finland, 1989-1992
Saxelin, M., Chuang, N.-H., Chassy, B., Rautelin, H., Makela, P. H., Salminen, S., & Gorbach, S. L. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.3.564 · Cited by 186
HELGELAND, L., VAAGE, J. T., ROLSTAD, B., MIDTVEDT, T., & BRANDTZAEG, P. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.d01-783.x · Cited by 122
Lactobacillemia in liver transplant patients
Patel, R., Cockerill, F. R., Porayko, M. K., Osmon, D. R., Ilstrup, D. M., & Keating, M. R. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.207 · Cited by 100
Lactobacillemia in three patients with AIDS
Horwitch, C. A., Furseth, H. A., Larson, A. M., Jones, T. L., Olliffe, J. F., & Spach, D. H. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1460 · Cited by 78 · cited 1×
“boulardii(111,112) and lactobacillaemia.(113,114) The source of the infection has usually been shown to be a commensal rather than an ingested probiotic supplement.”
Background
Cited by
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
Self-citationSartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,052
Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.019 · Cited by 859
Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766
Review article: prebiotics in the gastrointestinal tract
MACFARLANE, S., MACFARLANE, G. T., & CUMMINGS, J. H. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03042.x · Cited by 621
Metadata
- Authors
- Hart, A. L., Stagg, A. J., & Kamm, M. A.
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2003-02
- Volume
- 36
- Issue
- 2
- Pages
- 111-119
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W1994031544
- Cited by
- 103
- References
- 9
- FWCI
- 23.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Probiotics in the Treatment of Inflammatory Bowel Disease. https://app.cochat.ai/papers/10.1097/00004836-200302000-00005
- The paper
- Hart, A. L., Stagg, A. J., & Kamm, M. A. (2003). Use of Probiotics in the Treatment of Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. https://doi.org/10.1097/00004836-200302000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.